Ulocuplumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Ulocuplumab
Monoclonal antibody
Type Whole antibody
Source Human
Target C-X-C chemokine receptor type 4
Clinical data
Synonyms MDX-1338
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
Chemical and physical data
Formula C6486H9960N1720O2046S46
Molar mass 146.2 kg/mol

Ulocuplumab (MDX-1338) (INN[1]) is a monoclonal antibody designed for the treatment of hematologic malignancies.[2]

This drug was developed by Bristol-Myers Squibb.

References[edit]